Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APVO

Aptevo Therapeutics Inc

May 29 • 04:00PM ET

4.91

-0.09 -1.80 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-203.74	Insider Own	0.06%	Shs Outstand	1.25M	Perf Week	-2.58%
Market Cap	6.12M	Forward P/E	-	EPS next Y	-21.46	Insider Trans	0.00%	Shs Float	1.25M	Perf Month	2.08%
Enterprise Value	-3.99M	PEG	-	EPS next Q	-6.20	Inst Own	6.05%	Short Float	7.03%	Perf Quarter	-32.92%
Income	-27.92M	P/S	-	EPS this Y	72.35%	Inst Trans	2.44%	Short Ratio	1.62	Perf Half Y	-77.27%
Sales	0.00M	P/B	0.51	EPS next Y	11.07%	ROA	-197.08%	Short Interest	0.09M	Perf YTD	-47.93%
Book/sh	9.65	P/C	0.42	EPS next 5Y	38.04%	ROE	-549.01%	52W High	235.98 -97.92%	Perf Year	-94.20%
Cash/sh	11.66	P/FCF	-	EPS past 3/5Y	- 89.05%	ROIC	-183.81%	52W Low	3.80 29.21%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.38% 7.33%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	99.36%	Oper. Margin	-	ATR (14)	0.36	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.36	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.55	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.36	EPS Q/Q	99.60%	SMA20	0.46%	Beta	1.70	Target Price	21.00
Payout	-	Debt/Eq	0.38	Sales Q/Q	-	SMA50	3.36%	Rel Volume	0.38	Prev Close	5.00
Employees	36	LT Debt/Eq	0.30	Earnings	May 07	SMA200	-69.15%	Avg Volume	54.26K	Price	4.91
IPO	Jul 20, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	-14.46% -	Trades		Volume	20,718	Change	-1.80%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)